Innovation Pharmaceuticals Inc (IPIX)

[Phoenix300]

Kevetrin in excess of 200mg/m2 is coming and that news will be more evidence of this trial advancing along in a positive manner.
Cohort 8 is another big step!
I would not be surprised to learn of another company or two having signed confidentiality agreements with Cellceutix in the next few months as the interest in K grows.
The sideliners will be back ;)